Showing results (781-790 of 1,078) with videos related to

Sort By:
Pageof 108
Biomedical Materials (Bristol, England)|February 12, 2020
Three-dimensional porous composite scaffolds for in vitro marrow microenvironment simulation to screen leukemia drugZhi-Yu Shang, Hao Sun, Hong-Fei Xiang, et al.
Analytical Methods : Advancing Methods and Applications|September 15, 2020
Solid-phase microextraction using a β-ketoenamine-linked covalent organic framework coating for efficient enrichment of synthetic musks in water samplesLian Wen, Peng Wu, Lei-Lei Wang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|November 15, 2017
[Effects of bone marrow mesenchymal stem cell transplantation on retinal neovascularization in neonatal rats with oxygen-induced retinopathy]Qing-Jie Mu, Yue-Hua Zhao, Dan-Dan Cheng, et al.
Chemical Communications (Cambridge, England)|June 3, 2010
Enhanced saccharide sensing based on simple phenylboronic acid receptor by coupling to Suzuki homocoupling reactionSu-Ying Xu, Yi-Bin Ruan, Xing-Xing Luo, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinomaGuru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
The Lancet. Oncology|May 29, 2021
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, et al.
Urology|June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and ComplicationsClaire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) InvestigatorsJihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Pageof 108